David H. Munn
Department of Pediatrics
Medical College of Georgia
Augusta
USA
Name/email consistency: high
- Lineage-specific transcription factors in unexpected places. Munn, D.H. Eur. J. Immunol. (2010)
- Indoleamine 2,3-dioxygenase and tumor-induced tolerance. Munn, D.H., Mellor, A.L. J. Clin. Invest. (2007)
- Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. Munn, D.H. Curr. Opin. Immunol. (2006)
- GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Munn, D.H., Sharma, M.D., Baban, B., Harding, H.P., Zhang, Y., Ron, D., Mellor, A.L. Immunity (2005)
- IDO and tolerance to tumors. Munn, D.H., Mellor, A.L. Trends. Mol. Med (2004)
- Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. Munn, D.H., Sharma, M.D., Mellor, A.L. J. Immunol. (2004)
- Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. Munn, D.H., Sharma, M.D., Hou, D., Baban, B., Lee, J.R., Antonia, S.J., Messina, J.L., Chandler, P., Koni, P.A., Mellor, A.L. J. Clin. Invest. (2004)
- Macrophages and the regulation of self-reactive T cells. Munn, D.H., Mellor, A.L. Curr. Pharm. Des. (2003)
- Tolerogenic antigen-presenting cells. Munn, D.H. Ann. N. Y. Acad. Sci. (2002)
- Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Munn, D.H., Sharma, M.D., Lee, J.R., Jhaver, K.G., Johnson, T.S., Keskin, D.B., Marshall, B., Chandler, P., Antonia, S.J., Burgess, R., Slingluff, C.L., Mellor, A.L. Science (2002)
- Inhibition of T cell proliferation by macrophage tryptophan catabolism. Munn, D.H., Shafizadeh, E., Attwood, J.T., Bondarev, I., Pashine, A., Mellor, A.L. J. Exp. Med. (1999)